Download Powerpoint

Expression of the VLDL Receptor in Endothelial Cells
by Kathleen L. Wyne, Ravindra K. Pathak, Miguel C. Seabra, and Helen H. Hobbs
Arterioscler Thromb Vasc Biol
Volume 16(3):407-415
March 1, 1996
Copyright © American Heart Association, Inc. All rights reserved.
Permeabilized ldlA7 cells (A) and TR-2037 cells (B-F), which are ldlA7 cells that stably express
high levels of recombinant VLDLR protein, were either fixed and processed for indirect
immunofluorescence (B, C, and E) by using a polyclonal anti-VLDLR antibody (IgG-M404) or
incubated with DiI-labeled β-VLDL (D and F) as described in “Methods.” C and E, TR-2037 cells
were incubated with IgG-M404 in the absence (C) or presence (E) of permeabilizing agent in the
buffer.
Kathleen L. Wyne et al. Arterioscler Thromb Vasc Biol.
1996;16:407-415
Copyright © American Heart Association, Inc. All rights reserved.
Immunolocalization of the VLDLR in mouse skeletal muscle.
Kathleen L. Wyne et al. Arterioscler Thromb Vasc Biol.
1996;16:407-415
Copyright © American Heart Association, Inc. All rights reserved.
Immunoblot analysis of the VLDLR in tissue culture cells and bovine tissues.
Kathleen L. Wyne et al. Arterioscler Thromb Vasc Biol.
1996;16:407-415
Copyright © American Heart Association, Inc. All rights reserved.
Immunolocalization of VLDLR expression in bovine tissues.
Kathleen L. Wyne et al. Arterioscler Thromb Vasc Biol.
1996;16:407-415
Copyright © American Heart Association, Inc. All rights reserved.
Immunolocalization of the VLDLR, LDLR, and von Willebrand factor in cultured BCAECs.
BCAECs were stained with either nonimmune IgG (A), anti-VLDLR (B-D), anti-LDLR (E), or anti–
von Willebrand factor antibodies (F).
Kathleen L. Wyne et al. Arterioscler Thromb Vasc Biol.
1996;16:407-415
Copyright © American Heart Association, Inc. All rights reserved.